Daily Trades
- Dylan Jovine
Lots to discuss today, so I’m going to take them one at a time.
- Dylan Jovine
Because small biotech stocks have sold off this year, the stock price doesn’t reflect the company’s business prospects, so I am banging the table again on this one.
- Dylan Jovine
The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
- Dylan Jovine
Thirty years of investing has taught me that when it’s time to sell, it’s time to sell. There’s no point in crying about it.
- Dylan Jovine
In April, we sold half of our shares in Apellis Pharmaceuticals, Inc (SYM: APLS) at $85, a 76% increase from our recommended price of $48.42.
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
I recommend selling half your shares in Apellis Pharmaceuticals, Inc (SYM: APLS)
- Dylan Jovine
A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it.
deal of the month
Categories
Chinese Invasion of Taiwan as Early as 2025?
Dylan Jovine | China Blocks Rare Earth Exports: Major Priority for Trump’s Incoming Administration
Bleeding Out Russia in the War in Ukraine...
Recent posts
Tags
Connect with Us
- Dylan Jovine
Lots to discuss today, so I’m going to take them one at a time.
- Dylan Jovine
Because small biotech stocks have sold off this year, the stock price doesn’t reflect the company’s business prospects, so I am banging the table again on this one.
- Dylan Jovine
The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
- Dylan Jovine
Thirty years of investing has taught me that when it’s time to sell, it’s time to sell. There’s no point in crying about it.
- Dylan Jovine
In April, we sold half of our shares in Apellis Pharmaceuticals, Inc (SYM: APLS) at $85, a 76% increase from our recommended price of $48.42.
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
I recommend selling half your shares in Apellis Pharmaceuticals, Inc (SYM: APLS)
- Dylan Jovine
A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
